Vinit Shanbhag

Dr. Vinit Shanbhag

Department of Biochemistry, University of Missouri, Columbia, MO 65201, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
VSVinit Shanbhag
Vinit Shanbhag
KJKimberly Jasmer
Kimberly Jasmer
SZSha Zhu
Sha Zhu
AMAdam L. Martin
Adam L. Martin
NGNikita Gudekar
Nikita Gudekar
MPMichael J. Petris
Michael J. Petris
Significance: The family of copper-dependent lysyl oxidase (LOX) enzymes contributes to tumor metastasis. In this study, we show that the ATP7A copper transporter is required to deliver copper to LOX family members. Deletion of ATP7A inhibited LOX activity in breast and lung cancer cell lines, resulting in a significant loss of tumor growth and metastatic potential of these cells in mice. Elevated expression of ATP7A was found to be associated with reduced survival of breast cancer patients. Our study suggests that blocking the function of ATP7A could be an approach to inhibiting LOX-dependent malignancies.

8 May 2020 in Science
Verified
Journal Article
Closed access
PDF file
LGLiam M. Guthrie
Liam M. Guthrie
SSShivatheja Soma
Shivatheja Soma
SYSai Yuan
Sai Yuan
ASAndres Silva
Andres Silva
MZMohammad Zulkifli
Mohammad Zulkifli
JSJames C Sacchettini
James C Sacchettini
Elesclomol rescues Menkes disease mice: Menkes disease results from loss-of-function mutations in the P-type copper-transporting adenosine triphosphatase ATP7A. Children diagnosed with Menkes present with connective tissue abnormalities and neurodegenerative changes that result in death caused by severe copper deficiency, typically before 3 years of age. In the brain, lack of copper impairs cytochrome c oxidase (complex IV) in the electron transport chain, which leads to progressive neurological injury in Menkes patients. No treatment exists for Menkes disease because of the difficulty in supplying the brain with copper using traditional hydrophilic copper complexes such as copper histidine. Guthrie et al. developed a treatment involving the drug elesclomol that successfully alleviated disease symptoms in a mouse model of Menkes disease (see the Perspective by Lutsenko). Science , this issue p. 620 ; see also p. 584

2 October 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
ARAnanya Rakshit
Ananya Rakshit
KKKaustav Khatua
Kaustav Khatua
VSVinit Shanbhag
Vinit Shanbhag
PCPeter Comba
Peter Comba
ADAnkona Datta
Ankona Datta
We report highly selective, novel Cu 2+ chelators that relieve copper induced oxidative stress in vivo indicating applicability toward assuaging copper-overload disorders.

1 January 2017 in Journal of Cancer
Verified
Journal Article
Open access
SZSha Zhu
Sha Zhu
VSVinit Shanbhag
Vinit Shanbhag
YWYanfang Wang
Yanfang Wang
JLJaekwon Lee
Jaekwon Lee
MPMichael Petris
Michael Petris
The ATP7A protein is a ubiquitously expressed copper-translocating P-type ATPase that controls cytoplasmic copper concentrations by mediating cellular copper egress. In vitro studies have previously demonstrated that ATP7A abundance in various tumor cell lines is correlated with increased resistance to cisplatin, a widely-used chemotherapy agent. However, to date no studies have examined a role for ATP7A in tumor growth or cisplatin sensitivity in vivo. In this study, we deleted ATP7A in H-RAS transformed tumorigenic mouse embryonic fibroblasts (MEFRAS7A-). Interestingly, loss of ATP7A was found to markedly suppress tumorigenesis in MEFRAS7A- cells relative to wild type parental cells. This was associated with hyperaccumulation of copper and sensitivity to reactive oxygen species and hypoxia. Tumor grafts lacking ATP7A were markedly more sensitive to cisplatin chemotherapy compared to ATP7A-expressing control tumors. These findings identify ATP7A at the nexus between tumorigenesis and cisplatin resistance pathways, underscoring its potential as a therapeutic target for regulating both tumor growth and the efficacy of cisplatin treatment.

1 September 2017 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
ELErik Ladomersky
Erik Ladomersky
AKAslam Khan
Aslam Khan
VSVinit Shanbhag
Vinit Shanbhag
JCJennifer S. Cavet
Jennifer S. Cavet
JCJefferson Chan
Jefferson Chan
MPMichael J Petris
Michael J Petris
Copper is an essential yet potentially toxic trace element that is required by all aerobic organisms. A key regulator of copper homeostasis in mammalian cells is the copper-transporting P-type ATPase ATP7A, which mediates copper transport from the cytoplasm into the secretory pathway, as well as copper export across the plasma membrane. Previous studies have shown that ATP7A-dependent copper transport is required for killing phagocytosed Escherichia coli in a cultured macrophage cell line. In this investigation, we expanded on these studies by generating Atp7a LysMcre mice, in which the Atp7a gene was specifically deleted in cells of the myeloid lineage, including macrophages. Primary macrophages isolated from Atp7a LysMcre mice exhibit decreased copper transport into phagosomal compartments and a reduced ability to kill Salmonella enterica serovar Typhimurium compared to that of macrophages isolated from wild-type mice. The Atp7a LysMcre mice were also more susceptible to systemic infection by S . Typhimurium than wild-type mice. Deletion of the S . Typhimurium copper exporters, CopA and GolT, was found to decrease infection in wild-type mice but not in the Atp7a LysMcre mice. These studies suggest that ATP7A-dependent copper transport into the phagosome mediates host defense against S . Typhimurium, which is counteracted by copper export from the bacteria via CopA and GolT. These findings reveal unique and opposing functions for copper transporters of the host and pathogen during infection.

24 August 2017 in Molecules
Verified
Journal Article
Open access
PDF file
MEMarwa O. Elnahas
Marwa O. Elnahas
MAMagdy A. Amin
Magdy A. Amin
MHMohamed M. D. Hussein
Mohamed M. D. Hussein
VSVinit Shanbhag
Vinit Shanbhag
AAAmal Ali
Amal Ali
JWJudy Wall
Judy Wall
A Streptomyces strain was isolated from soil and the sequence of 1471 nucleotides of its 16S rDNA showed 99% identity to Streptomyces sp. HV10. This newly isolated Streptomyces strain produced an extracellular polysaccharide (EPS) composed mainly of glucose and mannose in a ratio of 1:4.1, as was characterized by Fourier transform infrared spectroscopy (FTIR), HPLC and 1H-NMR. The antioxidant activities of the partially purified MOE6-EPS were determined by measuring the hydroxyl free radical scavenging activity and the scavenging of 2,2-diphenyl-2-picryl-hydrazyl (DPPH) radicals. In addition, the partially purified MOE6-EPS showed high ferrous ion (Fe2+) chelation activity which is another antioxidant activity. Interestingly, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays that were colorimetric assays for NAD(P)H-dependent cellular oxidoreductases and a proxy of the number of viable cells, showed that the partially purified MOE6-EPS inhibited the proliferation of the human breast cancer cells (MDA-MB-231). The scratch wound assay showed that MOE6-EPS reduced the migration of mouse breast cancer cells (4T1). This study reports the production of EPS from Streptomyces species with promising antioxidant, metal chelating and mammalian cell inhibitory activities.